ArticleVirchows Archiv : an international journal of pathology2022

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status.

Josef Rüschoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.